Foreign Regulatory Seminar (Web-Based) - Office of Biostatistics and Epidemiology
Evaluation of Biological Product Safety Throughout the Lifecycle at FDA’s Center for Biologics Evaluation and Research
Detailed discussion on the safety and surveillance of biological products, including a description of monitoring approaches used at CBER, and pharmacovigilance planning by manufacturers.
Return to Foreign Regulatory Seminar (Web-Based)